| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |